The increase in fatty acid oxidation in the diabetic heart is associated with an increase in PPARα, which plays a key role in the development of cardiac hypertrophy and dysfunction in DCM (Madrazo and Kelly, 2008; Bayeva et al., 2013). The gene discussed is PPARA; the disease is familial dilated cardiomyopathy.